Filter
17
Filtered Results: 17
Text search:
Nam
Aidsmap
Featured
New Publications
3
Language
Document type
No document type
9
Studies & Reports
4
Fact sheets
3
Resource Platforms
1
Countries / Regions
Africa
2
Western and Central Europe
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
TB
4
HIV & STI
2
Toolboxes
Clinical Aspects
3
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2
Reports & Studies
2
Eastern Europe and central Asia
2
General Reports
1
Prevention Guidelines
1
Discrimination & Stigma
1
General
1
Simulations
1
Global Impact: Socio-economic, health services, TB & HIV
1
Information for the Public
1
Resource Platforms others
1
COVID-19
1
HIV &TB
1
Women
1
Eastern and Southern Africa
1
HIV & AIDS Treatment in Practice No. 198
HIV & AIDS Treatment in Practice No.202
HIV & AIDS Treatment in Practice No.199
HIV & AIDS Treatment in Practice No. 188
HIV & AIDS Treatment in Practice no. 201
• PrEP is highly effective in preventing the sexual transmission of HIV.
• For PrEP to work well, it’s important to take the pills regularly.
• While PrEP can prevent HIV, it does not protect against other sexually transmitted infections.
Version: 14 March 2019; A one-page reference guide to all the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions.
The previous edition of the drugs chart is also available to download in Russian.
Translated and adapted from the original English Antiretroviral drugs chart by the East Europe and Central Asia Union of People Living with HIV (ECUO). This resource shows drugs currently available in the Eastern Europe and Central Asia area.
Last update Oct. 2018
This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing thirty key questions about PrEP and how it might be implemented in the UK.
Accessed: 10.03.2020
Coronavirus and HIV. The impact of the new coronavirus pandemic on people with HIV, sexual health and HIV services. The new virus is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) while the illness it causes is coronavirus disease 2019 (COVID-19).
This report presents three scenarios on the impact of COVID-19 in Africa using economic growth forecasts, mortality and efforts to ameliorate impact through social grants. Likely effects are examined on per capita income, poverty and the attainment of selected Sustainable Development Goals targets. ...
1 July 2021; Report shows big COVID-19-related HIV prevention programme service disruptions, but highlights that HIV service innovations and adaptations are possible.
A synthesis report on programme disruptions and adaptations during the COVID-19 pandemic in 2020
